Table 2 Antimicrobial susceptibility pattern of clinical isolates of E. coli determined by disk diffusion
Antimicrobial agent | ISEC (n/%) | IREC (n(%)) | Total (n(%)) | ||||||
|---|---|---|---|---|---|---|---|---|---|
S | I | R | S | I | R | S | I | R | |
Meropenem | 100 | 0 | 0 | 0 | 0 | 4 (100) | 100 (96) | 0 | 4 (3.8) |
Fosfomycin | 96 | 0 | 4 | 4 (100) | 0 | 0 | 100 (96) | 0 | 4 (3.8) |
Nitrofurnatoin | 99 | 0 | 1 | 4 (100) | 0 | 0 | 103 (99) | 0 | 1 (0.96) |
Amikacin | 93 | 2 | 5 | 2 (50) | 0 | 2 (50) | 95 (91.3) | 2 (1.92) | 7 (6.7) |
Gentamicin | 70 | 0 | 30 | 1 (25) | 0 | 3 (75) | 71 (68.2) | 0 | 33 (31.7) |
Tetracycline | 32 | 0 | 68 | 2 (50) | 0 | 2 (50) | 34 (32.6) | 0 | 70 (67.3) |
Doxycycline | 30 | 7 | 63 | 2 (50) | 0 | 2 (50) | 32 (30.7) | 7 (6.7) | 65 (62.5) |
Chloramphenicol | 80 | 1 | 19 | 2 (50) | 0 | 2 (50) | 82 (78.8) | 1 (0.96) | 21 (20.1) |
Ciprofloxacin | 26 | 4 | 70 | 0 | 0 | 4 (100) | 26 (25) | 4 (3.8) | 74 (71.1) |
Ceftazidime | 50 | 20 | 30 | 0 | 0 | 4 (100) | 50 (48) | 20 (19.2) | 34 (32.6) |